In recent years, the Biotech Industry has witnessed a significant increase in the adoption of personalised medicine. The healthcare industry has come to the realisation that the traditional "one-size-fits-all" approach to medicine is no longer sufficient. With the abundance of research showing the importance of personalised medicine, it is increasingly clear that it represents the future of healthcare.
A key portion of personalized medicine is the rise of personalised supplements, which tailors treatments to each individual patient, as a way to improve health outcomes, reduce healthcare costs, and increase the overall quality of life. Regenosis is a Singapore-based geroscience biotechnology company that is on the cutting edge of this movement, providing customised treatments that address each patient's specific needs.
Led by Prof. Brian Kennedy, the Chief Scientific Director and Distinguished Professor of Biochemistry and Physiology at the NUS Yong Yoo Lin School of Medicine Professor, Regenosis develops therapies to reverse ageing and treat age-related diseases. Rejuvant, the cornerstone supplement of the brand, contains LifeAKG, a body-ready form of Calcium-Alpha-Ketoglutarate crucial for healthy cell function, so as to combat any health issues which may arise from aging. Studies from the Buck Institute on Ageing show Rejuvant's potential to reverse epigenetic ageing, increasing the healthiest years of life by 41% and reducing age-related frailty by 46%. Hence, ideal for those looking to improve their overall health and well-being.
In addition to personalised supplements, Regenosis offers cutting-edge Stem Cell Therapy. Designed to help patients maintain a youthful appearance and prevent the side effects that can come with traditional anti-ageing treatments. The therapy involves the collection of stem cells from the patient's own body, followed by their reintroduction into the patient's system at a later stage. The stem cells can help to regenerate and repair damaged tissues and organs, leading to better health and a reduced “biological age”.
On top of the treatments, the company has created RealHealth, a six-month personalised health and wellness program. By taking into account each patient's unique genetic makeup, lifestyle, and medical history, the program offers a range of personalised treatments including vitamins, stem cell collection and therapy for anti-ageing purposes, and a tailored approach to dietary supplementation, helping them to achieve optimal health and vitality.
With their long list of impressive achievements, Saltine Communications has successfully curated almost 40 features for the brand, seeking to highlight their expertise in gene editing, protein engineering, and synthetic biology, making it the leader in the geroscience field.
Saltine Communications is proud to be Regenosis’ PR agency on record for this campaign in Singapore. We’re honoured to be able to celebrate our clients’ achievements alongside them as their dedicated PR agency in Southeast Asia! Drop us a note at hello@saltinecomms.com to find out how we can get your brand onto the media at affordable rates.
As seen on: